Europe’s medical devices industry saw a rise of 31.58% in cross border deal activity during November 2021, when compared with the last 12-month average, led by Coloplast’s $2.49bn acquisition of Atos Medical, according to GlobalData’s deals database.

  • Embed this chart

    Embed this chart into your website

    Copy and paste the image source into your website to display the chart.


A total of 25 medical devices industry cross border deals worth $2.7bn were announced for the region in November 2021, against the 12-month average of 19 deals.

Of all the deal types, M&A saw most activity in November 2021 with 14 transactions, representing a 56% share for the region.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

In second place was venture financing with eight deals, followed by private equity deals with three transactions, respectively capturing a 32% and 12% share of the overall cross border deal activity for the month.

In terms of value of cross border deals, M&A was the leading category in Europe’s medical devices industry with $2.55bn, while venture financing and private equity deals totalled $114.74m and $12.73m, respectively.

Europe medical devices industry cross border deals in November 2021: Top deals

The top five medical devices cross border deals accounted for 97.8% of the overall value during November 2021.

The combined value of the top five medical devices cross border deals stood at $2.61bn, against the overall value of $2.7bn recorded for the month.

The top five medical devices industry cross border deals of November 2021 tracked by GlobalData were:

1) Coloplast $2.49bn acquisition deal with Atos Medical

2) The $49.52m acquisition of 17.8% stake in InnovHeart by Grand Pharmaceutical Group

3) Horizon Ventures and Sofinnova Partners $35m venture financing deal with Synthace

4) The $20.24m venture financing of QuantuMDx Group by Vita Spring IVD Fund

5) 415 Capital Management,Draper Esprit,Redalpine Venture Partners,Translink Capital and Verve Capital Partners $17.5m venture financing deal with Aktiia